Literature DB >> 11993715

Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging.

C Milochevitch1, A Khalil.   

Abstract

The purpose of this study was to investigate, with aging, the activity of two enzymes associated to HDL and responsible for its anti-atherogenic activity; paraoxonase (PON1) and platelet-activating factor acetylhydrolase (PAF-AH). Ninety-five subjects aged between 26 and 77 years were recruited for the study. The prevalence of phenotype A, AB, and B in our subjects group was 69.47,21.05 and 9.47% respectively. Plasma as well as HDL paraoxonase activity decreased significantly with aging (r =-0.218, P < 0.039) and (r = -0.280, P < 0.006) respectively. PAF-AH activity was unchanged with aging however, we noted a negative correlation between PAF-AH and PON1 activity in HDL (r = -0.243, P < 0.02) and in LDL vs HDL (r =-0.462, P < 0.001).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11993715     DOI: 10.1054/plef.2001.0320

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  7 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

2.  The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants.

Authors:  Mahmut Abuhandan; Alpay Cakmak; Abdullah Taskın; Emrah Karakaya; Abdurrahim Kocyigit; Hatip Kılıc
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

Review 3.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

4.  Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?

Authors:  Yuhua Sun; Yuejin Yang; Weidong Pei; Yongjian Wu; Jinglin Zhao
Journal:  Clin Cardiol       Date:  2007-11       Impact factor: 2.882

5.  Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?

Authors:  Kimberly A Davis; J Allen Crow; Howard W Chambers; Edward C Meek; Janice E Chambers
Journal:  Environ Health Perspect       Date:  2009-03-12       Impact factor: 9.031

6.  Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.

Authors:  Abdelghani Bounafaa; Hicham Berrougui; Noreddine Ghalim; Boubker Nasser; Abdallah Bagri; Abderrahmane Moujahid; Souad Ikhlef; Pamela Camponova; Najoua Yamoul; Olivier Kamtchueng Simo; Abdelkhalid Essamadi; Abdelouahed Khalil
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

7.  Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus.

Authors:  Mi Zhou; Xing-Hui Liu; Qing-Qing Liu; Meng Chen; Huai Bai; Lin-Bo Guan; Ping Fan
Journal:  J Diabetes Res       Date:  2020-02-03       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.